ETF profile for Bahl & Gaynor Income Growth ETF (BGIG) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
BGIG ETF Profile
| Family: |
Bahl & Gaynor |
| Name: |
Bahl & Gaynor Income Growth ETF |
|
|
| Inception Date: |
15-Sep-2023 |
| Termination Date: |
|
| Investment Objective: |
The Bahl & Gaynor Income Growth ETF is an actively managed ETF that invests primarily in dividend-paying U.S.-listed equity securities of large capitalization companies. In selecting securities, Bahl & Gaynor employs a bottom-up approach that considers, among other factors, a company's historical earnings and dividend growth, as well as its balance sheet and cash flow generation, and prospects for future cash flow and dividend growth. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| Microsoft Corp |
MSFT |
5.1800% |
| Taiwan Semiconductor Manufacturing Co Ltd |
TSM |
4.6400% |
| UnitedHealth Group Inc |
UNH |
4.5800% |
| AbbVie Inc |
ABBV |
4.4400% |
| Johnson & Johnson |
JNJ |
4.1500% |
| Chevron Corp |
CVX |
4.1100% |
| Broadcom Inc |
AVGO |
4.1000% |
| PNC Financial Services Group Inc/The |
PNC |
3.6800% |
| Eli Lilly & Co |
LLY |
3.1100% |
| Apollo Global Management Inc |
APO |
2.9500% |
|
Top 10 Holdings Weight: |
40.9% |
| Number of Holdings: |
54 |
| Shares Outstanding: |
61,162,547 |
| Total Net Assets: |
2,264,237,568 |
| NAV: |
37.00 |
| Net Expense Ratio: |
0.45% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
|
| Industry: |
|
| Dividend Type: |
Dividend - Regular Payors |
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Large Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
